Hudson Bay Capital Management LP 13D/13G Filings for Aptevo Therapeutics Inc. (APVO)

Hudson Bay Capital Management LP 13D and 13G filings for Aptevo Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-10
6:58 pm
Unchanged
2024-12-31 13G Aptevo Therapeutics Inc.
APVO
Hudson Bay Capital Management LP 76,598
4.990%
0
(Unchanged)
Filing
2025-02-10
4:24 pm
Purchase
2024-12-31 13G Aptevo Therapeutics Inc.
APVO
Hudson Bay Capital Management LP 76,598
4.990%
76,598increase
(New Position)
Filing